XRAY (DENTSPLY SIRONA Inc.) — AI Stock Analysis & Recommendation

Research of August 13, 2026 · Healthcare / Dental Equipment & Supplies

TradeFlare's AI research teams rate XRAY a BUY. The latest price is $8.51.

The research plan

• Entry: $11.41
• Time horizon: N/A

N/A

Why

Despite a recent earnings beat and some positive sentiment signals, the overwhelmingly bearish technical and fundamental outlook, coupled with high risk factors, makes XRAY a HOLD. The stock's trend is bearish, and fundamental analysis highlights significant financial distress and revenue challenges, which outweigh the short-term positive catalyst of the earnings surprise.

What could push XRAY higher

• Q2 earnings beat driven by turnaround plan progress.
• Insider buying activity.
• Positive analyst price target adjustments.

Key risks for XRAY

• Persistent unprofitability and negative net income.
• High debt-to-equity ratio indicating significant financial risk.
• Declining revenue year-over-year and weak full-year revenue guidance.

What each AI research team found

Fundamental team: Bearish · valuation: fair

Despite positive cash flow generation and a strong gross margin, Dentsply Sirona's persistent unprofitability, high debt, and declining revenue present significant headwinds. The current valuation appears fair, but the financial risks and lack of clear growth catalysts suggest a bearish outlook with potential downside.

• Persistent unprofitability with a negative net income TTM of -$546 million and a negative net margin of -14.99%.
• High debt-to-equity ratio of 172.24% indicates significant financial risk.
• Revenue has declined year-over-year by 4.1%, suggesting top-line challenges.

Technical team: Bearish

Despite a neutral trend and volume analysis, strong bearish momentum signals from MACD and Stochastic oscillators suggest a short-term downside move is probable. The price is currently testing resistance, and a failure to break through could lead to a decline towards the $10.50 support level.

• The price is consolidating between support at $11.09 and resistance at $11.63, with bearish short-term moving averages suggesting a potential move lower towards $10.50 if resistance holds.
• The stock is consolidating near support with mixed volume signals, but a recent volume spike suggests potential accumulation, warranting a neutral stance with a target at the next resistance level.
• Bearish momentum is confirmed by MACD crossover and declining Stochastic, suggesting a move towards the support level at $10.50.

Sentiment team: Neutral

XRAY's sentiment is currently neutral, reflecting a mixed bag of positive earnings surprises offset by ongoing revenue concerns and a cautious analyst consensus. While the company's turnaround plan shows some promise and insider buying is a positive, the weak revenue guidance and year-over-year sales decline temper optimism. The stable sentiment suggests no immediate strong directional conviction from the market.

• DENTSPLY SIRONA (XRAY) reported a Q2 earnings beat, driven by positive progress in its turnaround plan and insider buying, but concerns remain due to a weaker-than-expected full-year revenue forecast and a year-over-year revenue decline, leading to a...
• Dentsply Sirona (XRAY) shows a neutral sentiment driven by a Q2 earnings beat and positive analyst price target adjustments, but tempered by declining sales and concerns over future revenue guidance and past regulatory issues. (Score: 0.0)
• DENTSPLY SIRONA (XRAY) presents a mixed picture with Q2 earnings beating profit expectations but facing revenue headwinds and a predominantly 'Hold' analyst consensus, suggesting a neutral sentiment.

Risk team: High

XRAY presents a high-risk profile due to significant historical drawdowns, elevated volatility, high short interest, and substantial debt levels. The company's ongoing unprofitability further exacerbates these concerns. Consequently, a small position size with a tight stop-loss is recommended to manage the considerable downside risk.

• Deep 1-Year Drawdown: The stock has experienced a substantial drawdown of -77.26% over the past year, indicating significant past price depreciation and potential for further downside.
• High Realized Volatility: XRAY exhibits high realized volatility over the past 20 days (61.41% annualized), indicating significant price swings and potential for rapid losses.
• High Short Interest: Short interest is above 10%, which can amplify price movements during short squeezes or sharp declines, indicating bearish sentiment among a significant portion of market participants.

XRAY at a glance

Market value	$1.7B
Revenue growth (year over year)	-0.8%
Profit margin	-15.0%
Debt / equity	1.48

Every AI call on XRAY since June 16, 2026, and what happened next (4 calls) →

Research of August 13, 2026 · AI-generated analysis for educational purposes, can be wrong, not financial advice.